{"nct_id":"NCT04489888","title":"A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)","status":"COMPLETED","status_verified_date":"2025-06","start_date":"2020-10-27","start_date_type":"ACTUAL","primary_completion_date":"2023-02-20","primary_completion_date_type":"ACTUAL","completion_date":"2024-06-28","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["MRK"]}